News
#COVAXIN for Children: Study Demonstrates Robust Safety and Immunogenicity in 2-18 Years ... - Latest Tweet by DD News
The latest Tweet by DD News states, '#COVAXIN for Children: Study demonstrates robust safety and immunogenicity in 2-18 years old Volunteers Read More: ...'
#COVAXIN for Children: Study demonstrates robust safety and immunogenicity in 2-18 years old Volunteers
Read More: https://t.co/ybeKL3HB3C#Covaxin4Kids @MoHFW_INDIA @BharatBiotech @tapasjournalist @ pic.twitter.com/SwjNXtIQ28— DD News (@DDNewslive) December 30, 2021
(The above story first appeared on LatestLY on Dec 30, 2021 06:31 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
